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Aminorex identified in horse urine
following consumption of Barbarea vulgaris;
a preliminary report
George Maylin1, Clara Fenger2, Jacob Machin3, Sucheta Kudrimoti3, Rodney Eisenberg4, Jonathan Green5 and
Thomas Tobin3*
Abstract
Background: Aminorex, (RS)-5- Phenyl-4,5-dihydro-1,3-oxazol-2-amine, is an amphetamine-like anorectic and in the
United States a Drug Enforcement Administration [DEA] Schedule 1 controlled substance. Aminorex in horse urine
is usually present as a metabolite of Levamisole, an equine anthelmintic and immune stimulant. Recently, Aminorex
identifications have been reported in horse urine with no history or evidence of Levamisole administration. Analysis
of the urine samples suggested a botanical source, directing attention to the Brassicaceae plant family, with their
contained GlucoBarbarin and Barbarin as possible sources of Aminorex. Since horsepersons face up to a 1 year
suspension and a $10,000.00 fine for an Aminorex identification, the existence of natural sources of Aminorex
precursors in equine feedstuffs is of importance to both individual horsepersons and the industry worldwide.
Results: Testing the hypothesis that Brassicaceae plants could give rise to Aminorex identifications in equine urine
we botanically identified and harvested flowering Kentucky Barbarea vulgaris, (“Yellow Rocket”) in May 2018 in
Kentucky and administered the plant orally to two horses. Analysis of post-administration urine samples yielded
Aminorex, showing that consumption of Kentucky Barbarea vulgaris can give rise to Aminorex identifications in
equine urine.
Conclusions: Aminorex has been identified in post administration urine samples from horses fed freshly harvested
flowering Kentucky Barbarea vulgaris, colloquially “Yellow Rocket”. These identifications are consistent with
occasional low concentration identifications of Aminorex in equine samples submitted for drug testing. The source
of these Aminorex identifications is believed to be the chemically related Barbarin, found as its precursor
GlucoBarbarin in Kentucky Barbarea vulgaris and related Brassicaceae plants worldwide.
Keywords: Horse, Urine, Brassicaceae, Barbarea vulgaris, Aminorex, Drug testing
Background
Aminorex, (RS)-5-Phenyl-4,5-dihydro-1,3-oxazol-2-amine
(C9H10N2O, MW 162.19, Fig. 1) is an amphetamine-like
anorectic and central stimulant medication and a United
States Drug Enforcement Administration [DEA] Schedule
1 controlled substance. In the nineteen sixties, Aminorex
was marketed as a prescription appetite suppressant in
Europe but was withdrawn when it was found to be
associated with a significant incidence of cases of fatal pul-
monary hypertension [1].
In the United States Aminorex began to be identified
and reported as “positives” in equine samples in 2004,
starting in Ohio and later in Pennsylvania and Ontario,
totaling 80-plus identifications [2]. Aminorex is an Asso-
ciation of Racing Commissioners International [ARCI]
Class 1, Penalty class A foreign substance, associated
with a high potential for influencing a horse’s racing per-
formance owing to its stimulant properties. These iden-
tifications led to significant penalties against horsemen
[3] but the Aminorex identifications continued, indicat-
ing that horsemen were unaware of the source of these
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identifications [4]. Penalty A violations include a mini-
mum one-year suspension absent mitigating circum-
stances, a minimum fine of $10,000 (or 10% of the total
purse) for the trainer as well as disqualification of the
purse and placing of the horse on the Veterinarian’s List
for 180 days for the owner. (ARCI 2017), not insignifi-
cant penalties for a professional horseman.
Levamisole, an anthelmintic and immune stimulant
used in horses and livestock, was implicated as a source
of Aminorex identifications in 2007 [2]. Levamisole was
originally identified as an immune modulator for horses
in 1997 [5], and gained popularity as an adjunctive treat-
ment for Equine Protozoal Myeloencephalitis over the
following decade. In 2009 Ho et al. identified Levamisole
metabolites, Rexamino and Compound II, and con-
cluded that these metabolites could be co-identified with
Aminorex in cases where the Aminorex identification re-
sulted from treatment with Levamisole [6]. The associ-
ation of Levamisole with Aminorex led to the
classification of Levamisole by ARCI as a Class 2 Penalty
Class B foreign substance.
While the identification of Levamisole as a source of
Aminorex led to a sharp reduction in the number of
Aminorex identifications, it has not eliminated such
findings, and in North America sporadic unexplained
Aminorex identifications have occasionally been reported
[2]. Additionally, a number of recent Aminorex identifica-
tions have been reported in English sport horses where
there was no history of Levamisole administration and no
co-identifications of the expected metabolic markers of
Levamisole administration [7].
These findings suggested an Aminorex source other
than Levamisole and careful review of substances co-
identified in these samples showed a number of plant-
related, low molecular weight nitrogenous substances.
These findings and review of the botanical literature led
to the suggestion that GlucoBarbarin (Fig. 1) or its hy-
drolysis product Barbarin contained in certain plants
and originally identified in Barbarea vulgaris, the plant
from which the compound Barbarin was named, might
be the source of these Aminorex identifications [8].
Additionally, our English colleagues reported identifica-
tion of Aminorex in at least one presumably European
member of the genus Barbarea [7] in the Brassicaceae
family. Based on these reports, we identified a well-
known member of the Brassicaceae family which flowers
from late April to early May in Kentucky pasture, Yellow
Rocket (Barbarea vulgaris, Fig. 2) and harvested this
plant in flower for administration to horses, as we now
report. Further, we have also synthesized and chemically
purified Barbarin for use as a Certified Reference Analyt-
ical Standard and in enough quantities for equine
administrations if required [9]. This reference standard
was made available for use in the Aminorex related plasma
and urine analyses reported in this communication.
Results
Flowering Yellow Rocket plants were harvested, cleaned,
and administered to horses with pre- and post-
administration blood and urine test samples collected as
described in the Experimental section, below. Analyses
of serum and urine samples for Aminorex and Barbarin
were performed in the New York Drug Testing and
Research Program Laboratory using their International
Association of Standardization [ISO]-17,025 validated
analytical methods. Mass Spectral data obtained for
Aminorex in urine after Yellow Rocket administrations are
presented in Fig. 3. The chromatogram of an 8-h urine
extract scanned from 100 to 500 amu is shown in Fig. 3a.
Figure 3b shows the extracted protonated ions, masses 163
and 120 which were used to identify Aminorex in the com-
plex urine matrix of Fig. 3a. The Liquid Chromatography-
Fig. 1 Conversion of GlucoBarbarin (via Myrosinase) to Barbarin and Aminorex structure
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Mass Spectroscopy [LC/MS] data for the determination of
Aminorex in Yellow Rocket administrations are shown in
Fig. 4. The transition for Selected Ion Monitoring of Ami-
norex was 163.1 > 103.1. Panel A shows the chromatogram
of the pre-administration urine, Panel B shows a 4-h urine
extract, Panel C shows the chromatogram of a 12-h urine
extract, Panel D shows the chromatogram of an 8 h urine
extract, Panel E shows a pre-administration urine extract
and Panel F shows the chromatogram of the Aminorex
standard. All blood samples tested negative for Aminorex,
Fig. 2 Yellow Rocket, Barbarea vulgaris growing in Ithaca, NY, May 21th 2018
Fig. 3 a: Chromatogram of a post-8-h Yellow Rocket administration urine extract scanned from 100 to 500 am with the Aminorex peak identified.
Aminorex peak determined as such by the presence of the protonated ion of Aminorex at 163 am and the major daughter ion at 120 amu, as
shown in Fig. 3b. b: The extracted protonated ions, mass 163 (Aminorex parent ion) and mass 120 (major Aminorex daughter ion) which were
used to identify Aminorex in the complex urine matrix of Fig. 3a
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Fig. 4 (See legend on next page.)
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and both blood and urine samples tested negative for Bar-
barin. Pre-administration urine samples were all shown to
be negative for both Aminorex and Barbarin.
Discussion
The identification of Aminorex in urine samples from
horses administered Barbarea vulgaris is both consistent
with and supports the findings and interpretations of our
English colleagues [7]. Multiple members of the Brassica-
ceae family, including Barbarea vulgaris, produce Gluco-
Barbarin, which may be responsible for ongoing sporadic
Aminorex identifications reported in post-event equine
urine samples in the absence of evidence of Levamisole
administration. At this time, the precise mechanism for
the conversion of Barbarin to Aminorex is unclear, and it
is possible that some other compound produced by
Barbarea vulgaris is responsible. However, based on the
substantial structural similarities between Aminorex and
Barbarin, Barbarin is at this time the most likely candidate
for the primary source of Aminorex in the Brassicaceae
family.
The role of GlucoBarbarin in Brassicaceae is to serve
as a Barbarin precursor. When the plant is damaged, the
co-located enzyme, myrosinase, hydrolytically removes
the glucose molecule from GlucoBarbarin yielding an
intermediate which spontaneously cyclizes to Barbarin.
GlucoBarbarin then may act like other glucosinolates in
protecting the plant from potential predators [10]. Con-
sistent with this protective function of Barbarin, the Yel-
low Rocket plant material was refused by the experimental
horses until mixed with grass and sweet feed.
These findings are of practical significance for horse
racing regulation [11], in that there are now two inno-
cent, inadvertent, and completely unrelated sources of
Aminorex identifications in post-race urine samples. The
first innocent source is Levamisole, as a result of inadvert-
ent transfer of Levamisole from its use as an anthelmintic
or as an immune modulator, commonly recommended as
a component of treatment for Equine Protozoal Myeloen-
cephalitis. The second innocent source would be, as
reported here, exposure to Aminorex and/or Aminorex
precursors associated with inadvertent inclusion of plant
fragments of the Brassicaceae family in equine feedstuffs
and their subsequent ingestion by horses about to race.
Aminorex identifications in post-race urines following
Levamisole administration may be confidently identified
as Levamisole related if other post-Levamisole adminis-
tration metabolites, Rexamino and Compound II, de-
scribed by Ho et al. [12] are identified in the sample.
The inability to identify these other Levamisole metabo-
lites in the English sport horse samples initiated an
investigation for other likely sources of Aminorex, lead-
ing to identification of the Brassicaceae as a likely source
of post-race trace Aminorex identifications [7].
Based on the wide distribution of Barbarea vulgaris in
North America [Fig. 5] and the high level of sensitivity
of post-race testing, it seems likely that a background
level of sporadic inadvertent Aminorex identifications
will be ongoing in American racing. One approach to
addressing this issue is to identify biomarkers of expos-
ure to Brassicaceae plants, which would allow confident
identification of Brassicaceae as the source of these Ami-
norex identifications. At this time Barbarin, as has
recently been synthesized and certified by our research
program [9] would appear to be the first biomarker can-
didate for this role, but further research on administra-
tion of Brassicaceae and Barbarin itself to equines is
likely required in this area.
A limitation of this research is that, given the world-
wide distribution of Brassicaceae, we cannot at this time
identify the geographic extent of this potential problem.
A further concern is that the pharmacological signifi-
cance of low concentration urinary Aminorex identifica-
tions is unclear. Based on the behavioral observations of
Soma et al. [3] it seems that plasma concentrations of
Aminorex must be at least 2 ng/mL for pharmacological
effect. In fact, the brief five-minute duration of the
pharmacological responses to IV administration of 15
mg of Aminorex reported by Soma et al. [3] suggests
that these pharmacological responses are transient local
high CNS concentration bolus responses, followed imme-
diately by complete loss of pharmacological effect. Con-
sistent with this interpretation, oral 15mg administration
of Aminorex produced no observable pharmacological
responses. Given the fact that this orally ineffective dose
produced urinary concentrations of Aminorex averaging
about 75 ng/mL, it seems reasonable to suggest that urin-
ary concentrations of Aminorex less than 75 ng/mL are
unlikely to be associated with pharmacological effects.
With respect to identifying a Screening Limit of Detec-
tion (SLOD) for Aminorex in post-race urines, a cut-off /
SLOD should be “high enough to cut-off the environmental
(See figure on previous page.)
Fig. 4 The 6470 Triple Quadrupole LC/MS data for the determination of Aminorex in pre- and post- Yellow Rocket administration urines. The
transition for Selected Ion Monitoring of Aminorex was 163.1 > 103.1. a shows the chromatogram of the pre-administration urine extract, b shows
the chromatogram of a 4 h post–administration urine extract, c shows the chromatogram of a 8 h post–administration urine extract, d shows the
chromatogram of a 12 h post–administration urine extract, e shows the chromatogram of a pre-administration urine extract demonstrating no
carry-over, and f shows the chromatogram of the Aminorex reference standard. No evidence for the presence of Barbarin in these post B. vulgaris
administration blood or urine samples has been identified to date
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noise and low enough to stop performance enhancement”
as described in [15]. Given that a sequence of five urinary
Aminorex identifications of unknown origins in Massa-
chusetts during 2017 were all less than 20 ng/mL it would
seem reasonable to set a urinary interim Screening Limit
of Detection of 30 ng/mL (Fenger, personal communica-
tion, July 2019), in the absence of a significant number of
data points on which to base a more complete analysis.
In presenting this interim 30 ng/mL SLOD we particu-
larly note the unusually long terminal plasma half-life of
Aminorex, 46.6 h in one horse in the Soma study. This
terminal plasma half-life means that individual horses
exposed to an ongoing dietary source of Barbarin will
accumulate urinary concentrations over a nine-to-ten-
day period, increasing the probability of attaining detect-
able urinary concentrations of Aminorex. Given this
circumstance, it is important that reported Aminorex
identifications include best good faith estimates of the
concentrations of Aminorex identified. These data will
allow evaluation of the contributions of geographically
different environmental sources to urinary Aminorex
identifications and the above interim Screen Limit of
Detection can be adjusted if required, following the
model presented by [16].
Other species within the Brassicaceae family may be
similarly implicated as likely candidates for the introduc-
tion of GlucoBarbarin/Barbarin to animals. The plant Res-
eda luteola, more commonly known as “weld” or Dyer’s
Rocket is similarly known to produce GlucoBarbarin [17].
This plant is widely distributed throughout Europe and
has been introduced to many parts of the United States.
Historically used as a source of yellow dye, it was also
grown domestically for its sweet aromatic smell. Based on
the results herein reported with respect to Barbarea
Fig. 5 Distribution of Yellow Rocket, Barbarea vulgaris, in the United States; Data re-constructed from USDA reports [13]. The British Isles show
similar distribution, with only parts of Scotland having none reported as of May, 2019 ([14]
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vulgaris it is reasonable to assume that if Reseda luteola
were to be ingested a measurable level of Aminorex might
also be detectable in equine urine.
Conclusion
In conclusion, oral administration of Barbarea vulgaris /
Yellow Rocket plant material to two horses has resulted in
urinary Aminorex identifications. The proximate chemical
source of these Aminorex identifications is likely to be
GlucoBarbarin/Barbarin, long-recognized components of
the Yellow Rocket plant. Given these circumstances and
the widespread distribution of such plants in North Amer-
ica and elsewhere, Yellow Rocket or related Brassicaceae
plants are likely sources of sporadic low-concentration
Aminorex identifications in the sports horse worldwide.
Future research will focus on identifying biomarkers of
Yellow Rocket or other Brassicaceae to definitively identify
botanical origins for Aminorex identifications and the ac-
quisition of enough field data to support or appropriately
adjust our proposed 30 ng/mL environmental “cut-off” or
Screening Limit of Detection (SLOD) for pharmacologic-
ally and forensically insignificant Aminorex identifications
in equine drug testing.
Methods
Yellow rocket identification and harvest
Barbarea vulgaris plants in bloom were harvested from
a central Kentucky pasture in mid-May, 2018, with the
landowner’s consent and consistent with State of Ken-
tucky plant harvesting regulations. The harvest plants
were identified as Barbarea vulgaris / Yellow Rocket by
Dr. J. D. Green of the Department of Plant and Soil Sci-
ences of the University of Kentucky. Briefly, stems were
ribbed and hairless with shiny dark leaves located in
basal rosettes. Basal leaves were stalked with a large ter-
minal lobe and smaller lower lobes. All leaves were alter-
nate with wavy and toothed margins. The flowers were
present in terminal clusters above the foliage. The iden-
tified plants were cleaned of extraneous material and
shipped overnight to the New York State Drug Testing
and Research Program for equine administration and
forensic analysis and equine administration.
Animal administration and sample collection procedures
The entire plant, including roots, leaves, stems and flowers
were ground to a fine texture in an Oster Total Prep 10-C
Food Processor. A total of 0.45 kg of wet weight processed
plant material was presented to each of two horses. Bar-
barea vulgaris plant material was refused by the horses
when presented alone but was readily consumed when
mixed with an equivalent amount of sweet feed and fresh
cut grass. Blood and urine samples were collected as pre-
administration zero-time samples and then at 4, 8, and 12
h post administration.
Mature Standardbred mares weighing between 400 and
540 kg and aged 8 and 11 years were used for these admin-
istration experiments. These horses were part of the New
York State Drug Testing and Research Program research
herd and were in good health and monitored by experi-
enced veterinary clinicians. Mares were maintained in their
home box stalls and all sample collections and substance
administrations were performed in their home stalls. Blood
samples were collected by jugular venipuncture and urine
samples by bladder catheterization and draining of the
bladder at the indicated time intervals, as previously
described [18]. Blood samples were allowed to clot, then
centrifuged at 1500 g for 10 m and the serum decanted
and stored at -20 °C until analysis. Urine samples were
similarly aliquoted, sealed, and stored at -20 °C until ana-
lysis. All physical analyses occurred within 20 days of col-
lection. All samples were collected under the supervision
of New York State Drug Testing and Research Program
personnel and transferred to the New York State Drug
Testing and Research Program laboratory where they were
logged in as dated and numbered research samples.
Extraction
Aminorex was extracted from 4.0 ml urine samples
adjusted with pH 9.5 carbonate buffer using 4.0 ml of
ethyl acetate/hexane solvent (9: 1 v/v). The samples were
mixed on a rotary mixer and centrifuged for 1 0 min
each. The organic phases were transferred to concentra-
tion tubes and evaporated to dryness in a 50 °C water
bath under nitrogen flow. The residues were reconsti-
tuted in methanol for LC/MS analysis.
Liquid chromatography/mass spectrometry
An Agilent Technologies 6150 B Quadrupole LC/MS
System and an Agilent 64 70 Triple Quadrupole LC/MS
System in positive ionization modes were used for
screening and confirmatory analysis respectively. Each
instrument used 1290 Infinity Auto Injectors and
thermostated column compartments. The 6150B used
an Agilent Eclipse AAA, 3 × 100 mm liquid chromatog-
raphy column. The LC gradient consisted of 100% A
(100%/0.1%formic acid) for 5 min and then a linear gra-
dient to 100% B (90% methanol/10% 0.1 formic acid) at
20 min at a flow of 0.4 mL/minute. Column compart-
ment was 40 °C. The 6470 Triple Quadrupole used an
Agilent Poroshell EC-120, 3.0 × 100 LC column. An LC
gradient of acetonitrile/formic acid in the following
composition was used: (90% formic acid/10% aceto-
nitrile) for 1 m, (5% formic acid/95% acetonitrile) for
4.5 min and (90% formic acid/10% acetonitrile) at 5 min.
Flow rate was 0.4 ml/minute and column temperature
was 50 °C. Limit of Detection was 1 ng/mL and urinary
concentrations of Aminorex were estimated to be
approximately in the range of 10 ng/ml. No Aminorex
Maylin et al. Irish Veterinary Journal           (2019) 72:15 Page 7 of 8
was detected in the post-administration plasma samples,
and no Barbarin was detected in either the plasma or
urine samples.
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